ClinicalTrials.govpublic full text
The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease
alzheimer's disease, neramexane, nmda receptor antagonist, memory loss, alzheimer disease, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 860431
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.